News
Nutrileads wins Immune Health Award with BeniCaros
Venture Challenge alumnus NutriLeads BV announced today that its patented immune health ingredient BeniCaros® has won the 2022 Nutrition Industry Executive award for the Immune Health category. Each year the
Meet the teams: Venture Challenge Fall 2022
Last week five teams started their Venture Challenge adventure with the first 3-day bootcamp. Already in these three days the teams made huge progress.
SeraNovo and Ildong Pharmaceutical to collaborate on research projects
SeraNovo BV (Leiden, the Netherlands) is pleased to announce the closing of a multi compound deal with Ildong Pharmaceutical (Seoul, South Korea), a pharmaceutical company engaged in the research and development of small molecules in the field
Iprotics Wins the Venture Challenge Spring 2022!
The winner of the Venture Challenge was announced today at the Dutch Biotech Event. The proud winner of the 2022 spring edition is
Great MedtechMeeting today with lots of matches
Today our MedtechMeeting was located at the impressive NEXT Delft hosted by DEMCON
Chaincraft raises €11mln to produce biochemicals from waste
Venture Challenge alumnus ChainCraft, active in the production of sustainable biobased chemicals, has closed a EUR 11 million financing round.
Venture Challenge Alumnus ShanX Medtech a step closer to market with Eurostars grant
Hundreds of millions of people suffer from Urinary Tract Infections (UTIs) every year worldwide. With the majority of UTIs stemming from a bacterial infection, the treatment thereof is straightforward: an antibiotic prescription.
On September 19th the Venture Challenge Fall 2022 will commence!
During an intense 10 weeks, the 5 selected teams will develop a solid business case to bring their scientific invention to market and benefit researchers, doctors and patients.
Innovation by Predica Diagnostics BV improves cervical cancer screening
First investment from ION+2 innovation fund
Eurostars #1: Praxa Sense’s AMBULAS project
Praxa Sense is proud to announce its success in the most recent Eurostars round, where they ranked number 1 out of all 428 applications in Europe. With the AMBULAS project we will further develop our sensor system, the most accurate remote monitoring device for continuous passive measurements in an ambulant environment of (among others) ECG, blood oxygen saturation, temperature and movement. The combination of these measurements are highly valued in remote monitoring in multiple care paths.